It has been a mixed year for AN2 Therapeutics, Inc. insiders: $12,000 bought by one person and $398,000 sold by six, so more selling than buying overall.
Biggest single buyer: FitzPatrick Margaret M, Director, with roughly $12,000.
Big money check: 66 institutions held ANTX as of Q2 2026, and more funds bought than sold. 4 quarters in a row of net selling by insiders. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Readnour Robin Shane | Director | Sell | 585 | $6.02 | $4K | SEC |
| Sep 11, 2026 | Readnour Robin Shane | Director | Sell | 523 | $6.02 | $3K | SEC |
| Sep 8, 2026 | Readnour Robin Shane | Director | Sell | 4,725 | $6.02 | $28K | SEC |
| Sep 8, 2026 | Readnour Robin Shane | Director | Sell | 2,877 | $6.07 | $17K | SEC |
| Sep 8, 2026 | Readnour Robin Shane | Director | Sell | 3,223 | $6.07 | $20K | SEC |
| Sep 8, 2026 | Readnour Robin Shane | Director | Sell | 5,294 | $6.02 | $32K | SEC |
| Sep 4, 2026 | Williams Sarah Joanne | Officer | Sell | 272 | $5.53 | $2K | SEC |
| Sep 2, 2026 | FitzPatrick Margaret M | Director | Buy | 2,098 | $5.53 | $12K | SEC |
| Aug 19, 2026 | Readnour Robin Shane | Director | Sell | 16,696 | $6.01 | $100K | SEC |
| Aug 19, 2026 | Readnour Robin Shane | Director | Sell | 18,706 | $6.01 | $112K | SEC |
| Jul 10, 2026 | Eizen Joshua M | Officer | Sell | 5,945 | $4.17 | $25K | SEC |
| Jun 2, 2026 | Williams Sarah Joanne | Officer | Sell | 265 | $4.43 | $1K | SEC |
| Mar 5, 2026 | Williams Sarah Joanne | Officer | Sell | 327 | $1.06 | $347 | SEC |
| Jan 7, 2026 | Day Lucy | CFO | Sell | 5,512 | $1.01 | $6K | SEC |
| Jan 7, 2026 | Prior Stephen David | Executive Officer | Sell | 2,858 | $1.01 | $3K | SEC |
In the last 12 months AN2 Therapeutics, Inc. insiders made open-market purchases worth about $12,000 and sales worth about $398,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in ANTX was filed on 2026-09-11.
66 investment managers reported holding ANTX in SEC Form 13F filings for Q2 2026.
No congressional trades in ANTX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).